Christophe Jean
Director/Board Member at RHYTHM PHARMACEUTICALS, INC.
Net worth: - $ as of 2024-03-30
Profile
Christophe R. Jean is on the board of Rhythm Pharmaceuticals, Inc. and European Biopharmaceutical Enterprises. In the past Mr. Jean occupied the position of EVP-Strategy & Business Development at Ipsen SA and EVP-Strategy & Business Development at Ipsen Pharma SAS (a subsidiary of Ipsen SA), Head-Europe, Middle East & Africa at Novartis AG President-Europe, Middle East & Africa at Novartis Pharmaceuticals Corp. and Financial Controller & Head-Finance at Ciba-Geigy AG (both are subsidiaries of Novartis AG), Chairman & Chief Executive Officer at Pierre Fabre Médicament SAS and Managing Director at Ipsen Pharma SA. Mr. Jean received an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-20 | 0 ( -.--% ) | - $ | 2024-03-30 |
Christophe Jean active positions
| Companies | Position | Start |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Director/Board Member | 2015-03-31 |
B Cell Design SAS
 B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Director/Board Member | - |
eureKING SA
 eureKING SA Financial ConglomeratesFinance eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France. | Founder | - |
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Director/Board Member | - |
Back to Basics, Inc.
 Back to Basics, Inc. Food RetailRetail Trade Back to Basics, Inc. is an American company that is currently open for business. The private company prioritizes the safety of their staff and their families, especially those who are in high-risk groups. Customers are required to wear masks when entering the store. | Director/Board Member | - |
Former positions of Christophe Jean
| Companies | Position | End |
|---|---|---|
| IPSEN | Chief Operating Officer | 2013-10-31 |
Exonhit
 Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Director/Board Member | 2012-12-19 |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Director/Board Member | 2007-12-31 |
Pierre Fabre Group
 Pierre Fabre Group Household/Personal CareConsumer Non-Durables Pierre Fabre Group manufactures cosmetics and skincare products. The private company is based in Paris, France. The CEO of the French company is Eric Ducournau. | Corporate Officer/Principal | 2001-12-31 |
| ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Christophe Jean
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| IPSEN | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| EUROBIO SCIENTIFIC | Health Technology |
| Private companies | 14 |
|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
Ipsen Pharma SA
 Ipsen Pharma SA Pharmaceuticals: MajorHealth Technology Ipsen Pharma SA manufactures and distributes pharmaceutical products. It supplies products to the therapeutic areas such as oncology, endocrinology, and neuromuscular disorders. The firm also develops drugs for gastroenterology, cognitive disorders, and cardiovascular diseases. Ipsen Pharma is headquartered in Sant Feliu de Llobregat, Spain. | Health Technology |
Keosys SAS
 Keosys SAS Medical SpecialtiesHealth Technology Keosys SAS specializes in imaging and communication systems for nuclear medicine and radiology. It engages in medical imaging, telecommunication and information technology services. The firm develops products and services for medical diagnosis and clinical trials. The company was founded in 2001 and is headquartered in Saint-Herblain, France. | Health Technology |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
European Biopharmaceutical Enterprises
European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Health Technology |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
Pierre Fabre Group
Pierre Fabre Group Household/Personal CareConsumer Non-Durables Pierre Fabre Group manufactures cosmetics and skincare products. The private company is based in Paris, France. The CEO of the French company is Eric Ducournau. | Consumer Non-Durables |
eureKING SA
eureKING SA Financial ConglomeratesFinance eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France. | Finance |
B Cell Design SAS
B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Commercial Services |
Back to Basics, Inc.
Back to Basics, Inc. Food RetailRetail Trade Back to Basics, Inc. is an American company that is currently open for business. The private company prioritizes the safety of their staff and their families, especially those who are in high-risk groups. Customers are required to wear masks when entering the store. | Retail Trade |
- Stock Market
- Insiders
- Christophe Jean
